EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: Outcomes in Asian populations

Kim E.S.Melosky B.Park K.Yamamoto N.CHIH-HSIN YANG2022-08-102022-08-1020211479-6694https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106932597&doi=10.2217%2ffon-2021-0195&partnerID=40&md5=b36f999ca632bb5d04b1be26486a0d9dhttps://scholars.lib.ntu.edu.tw/handle/123456789/616503[SDGs]SDG3[SDGs]SDG17EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: Outcomes in Asian populationsreview10.2217/fon-2021-0195338558652-s2.0-85106932597